Please use this identifier to cite or link to this item:
|Title:||In reply: The emerging value of molecular forms of B-type natriuretic peptide in heart failure|
|Authors:||Israr, M. Zubair|
Heaney, Liam M.
|Publisher:||AME Publishing Company|
|Citation:||Journal of Laboratory and Precision Medicine, 2017, 2:23.|
|Abstract:||We would like to commend Drs Yang and Wang for their forward-thinking perspectives and positive implications of the clinical measurements of molecular forms of B-type natriuretic peptide (BNP) (1). We share the view that these processed forms of BNP can provide beneficial clinical information for cardiovascular disease prognoses and therapeutic monitoring with an emphasis on personalized medicine. We have previously demonstrated the prognostic capabilities of BNP molecular forms in the acute setting through measurement in acute heart failure (HF) patients (2), and support the further investigation of these forms across cardiovascular conditions.|
|Embargo on file until:||1-Jan-10000|
|Rights:||Copyright © 2017, Journal of Laboratory and Precision Medicine. All rights reserved..|
|Description:||The file associated with this record is under embargo while permission to archive is sought from the publisher. The full text may be available through the publisher links provided above.|
|Appears in Collections:||Published Articles, Dept. of Cardiovascular Sciences|
Files in This Item:
|Israr et al - J Lab Precis Med - In reply The emerging value of molecular forms of B-type natriuretic peptide in heart failure.pdf||Published (publisher PDF)||102.52 kB||Adobe PDF||View/Open|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.